Webcast/CME - Clinical Experience with Vorinostat in CTCL and Sézary Syndrome

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Dermatology Other

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Dermatology Other

	Advances in Dermatological Care: What the Family Physician Needs to Know
	Distinguishing Pemphigus and Pemphigoid for the Non-Dermatologist
	Actinic Keratoses: What You Must Know About Prevention, Diagnosis, and Treatment
	Don't Sweat it: Epidemiology, Pathophysiology, and Treatment of Hyperhidrosis

Recent news - Dermatology Other

	Linezolid Shows Efficacy for Complicated Skin and Soft-Tissue Infections: Presented at ECCMID - (DGDispatch)
	Iclaprim Eradicates Complicated Skin and Skin Structure Infections: Presented at ECCMID - (DGDispatch)
	Becaplermin May Increase Risk of Death From Cancer in Patients With Diabetes - (DGNews)
	As Use of Biologicals Rises, So Too Will Cutaneous Reactions to Them: Presented at AAAAI - (DGDispatch)
	FDA Approves Rilonacept for the Treatment of Rare Inflammatory Syndromes - (DGNews)

Recent cases - Dermatology Other

	Esophageal Squamous Cell Carcinoma Presenting with Extensive Skin Lesions: A Case Report
	Selective IgM Deficiency Accompanied with IgG4 Deficiency, Dermal Complications and a Bronchial Polyp
	Giant Pyogenic Granuloma of the Thigh: A Case Report
	Atypically Distributed Cutaneous Lesions of Norwegian Scabies in an HIV-Positive Man in South India: A Case Report
	Merkel Cell Carcinoma of the Upper Extremity: Case Report and Update

personal edition > dermatology other > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Clinical Experience with Vorinostat in CTCL and Sézary Syndrome

Presented by:	The University of Kentucky College of Medicine
Lecturer	Francine Foss, MD
Approximate duration:	Not available
Summary points:	This audiovisual presentation discusses the classifications of cutaneous T-cell lymphoma and Sézary syndrome, the epidemiology and aetiology of mycosis fungoides, disease-specific survival rates, clinical responses to various therapies and immunotherapy, treatment of advanced stage/refractory patients, data from the Depsipeptide Phase 2 study, and evidence from clinical trials of vorinostat, known drug-related adverse effects.
Accreditation:	The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The University of Kentucky College of Medicine designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits. Expiration date: January 1, 2007.
Other:

Additional Information